Heart retracts stent-ReoPro paper over data dispute with authors (save one)
We’re a few months late on this one, but Heart, a BMJ title, issued a fascinating retraction notice in August about a meta-analysis on percutaneous coronary intervention (that’s stenting to you and me) after suffering a heart attack, and the drug abciximab, which is used to prevent clotting and additional near-term heart attacks. Abciximab is … Continue reading Heart retracts stent-ReoPro paper over data dispute with authors (save one)